Med Ed Report briefs: June 2012

Share this article:
Med Ed Report briefs: June 2012
Med Ed Report briefs: June 2012

Online doctor portal Sermo will get video and rich media from TheVisualMD, firms said. Sermo health-education centers will combine member discussion on clinical cases, KOL content and research institutions with tools incorporating MRI, CT and 3D microscopy data.

Hospital-based MDs registered a 0.5% decrease in engagement level, from 4.17 in 2010 to 4.12 in 2011, survey firm Morehead reported. Regression analysis revealed nine key drivers of engagement, with hospital-sponsored CME appearing on the list for the first time (3.72).

Happtique is recruiting physicians to test technology designed to let doctors prescribe mHealth apps to patients. Participants will receive training and access to a subset of specialty-specific apps.

The ACCME board ratified 46 accreditation and reaccreditation decisions. Of these, 19 were accredited with commendation; 19 were accredited; and eight had to submit progress reports. Three were put on probation.

Database marketing firm DMD named Jim Ufheil SVP, sales. Ufheil will head DMD's efforts in CME, physician recruitment and academia.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?